Last reviewed · How we verify
NCT06612528
Transcranial Direct Current Stimulation on Singer's Voice
NA trial testing tDCS in Voice in 30 participants. Enrolling by invitation.
10 September 2024
Quick facts
| Lead sponsor | Universidade Federal de Pernambuco |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 11 March 2024 |
| Primary completion | 10 September 2024 |
| Estimated completion | 20 June 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- tDCS — full drug profile →
- Flexible tube in water
Conditions studied
- Voice — all drugs for Voice →
- Voice Range Profile — all drugs for Voice Range Profile →
- Voice Quality — all drugs for Voice Quality →
Sponsor
Universidade Federal de Pernambuco — full company profile →
Who can join
Adults 18 to 45, any sex, with Voice or Voice Range Profile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Transcranial direct current stimulation (tDCS) can be used to temporarily and reversibly modulate brain functions and is an increasingly utilized tool to investigate the relationships between brain and behavior. This study aimed to identify the effects of tDCS on vocal quality, vocal range, neuromotor functioning of the larynx and self-reported vocal effort in vocally healthy singers. This is a triple-blinded, sham-controlled, randomized clinical trial. The participants will be randomized to one of the three tDCS groups (primary motor cortex, cerebellum or sham). In each group a voice training will be applied at the same tDCS time. The three groups are: (i) cerebellum; (ii) primary motor cortex (M1); (iii) sham. The tDCS parameters in the active groups are anodal - 2mA for 20 minutes, at the sham group the stimuli are finished 30 secondes before starting. Volunteers will pass for 10 intervention days and they will be evaluated for vocal performance before the sessions, in the day 5 of intervention, the last day of intervention (day 10) and 1 month later for follow up evaluation. Voice recordings will be take to assess the following vocal parameters: vocal range profile (VRP) at weak and strong intensities; vocal quality (jitter, shimmer, irregularity, glottal-to-noise excitation ratio, and dysphonia acoustic index) at weak, habitual, and strong intensities; laryngeal diadochokinesis, and self-reported vocal effort using the adapted Borg CR10 scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06612528
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of tDCS
Trials testing the same drug.
- NCT07400939 — Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke · NA · recruiting
- NCT06994390 — Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial) · NA · not yet recruiting
- NCT07358832 — Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease · NA · recruiting
- NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
- NCT06972368 — Home-Based tDCS for Depression in BPD · NA · recruiting
Other recruiting trials for Voice
Currently open trials in the same condition.
- NCT07262632 — Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment · recruiting
- NCT05319678 — Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users · recruiting
Other Universidade Federal de Pernambuco trials
Trials by the same sponsor.
- NCT07366411 — taVNS on Functional Mobility in People With DP · Phase 2 · not yet recruiting
- NCT07132021 — Efficacy of Trans-auricular Vagus Nerve Stimulation on Upper Extremity Motor Recovery in Stroke Survivors · Phase 2 · recruiting
- NCT07149233 — Effectiveness of Inspiratory Muscle Training on Sleep in Patients With Obstructive Sleep Apnea · NA · enrolling by invitation
- NCT06886386 — TsDCS and Physical Therapy After Incomplete Spinal Cord Injury · NA · enrolling by invitation
- NCT07523126 — EFFECT OF TRANSCUTANEOUS ELECTRONEURO-STIMULATION OF THE VAGUS NERVE ON JOINT PAIN SEQUELAE OF CHIKUNGUNYA FEVER IN THE · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06612528 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal de Pernambuco
- Last refreshed: 25 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06612528.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing